Recruiting

Behavioral Parenting Skills

Sponsor:

Roswell Park Cancer Institute

Code:

NCT06074666

Conditions

Acute Lymphoblastic Leukemia, Pediatric

Eligibility Criteria

Sex: All

Age: 3 - 9

Healthy Volunteers: Not accepted

Interventions

CareMeds Intervention

Usual Care Group

Study Details

Brief summary:

The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.

Conditions

Acute Lymphoblastic Leukemia, Pediatric

Study ID

NCT06074666

Start date

Nov 7, 2024

Status verified date

Apr, 2026

Completion date

Oct 1, 2027

Anticipated

Primary completion date

Oct 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 3 - 9

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
  • Parent has primary medication responsibility.
  • Pediatric patient aged 3-9 years
  • Child on therapy that includes home-based oral anti-cancer medication, such as 6-MP.
  • Parent has verbal English or Spanish fluency.
  • Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure

Exclusion Criteria:

  • Parent is unwilling or unable to follow protocol requirements

Study Design

Enrollment

100 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: CareMeds Intervention

Participants complete the CareMeds parent training sessions during weeks 2, 3 and 4.

active comparator: Usual Care

Usual care consists of medical consultations and supportive care, The usual care group will serve as a delayed intervention/wait list group for which 3 parent training sessions will be offered during weeks 13 through 15.

Interventions

CareMeds Intervention

3 parenting sessions will be offered during weeks 2 through 4 of the study period.

Usual Care Group

3 parenting sessions will be offered during weeks 13 through 15 of the study period.

Primary outcome measure

  • Feasibility of the CareMeds 3 sessions [ Time Frame: up to 3 years ]

Central Contacts and Locations

Central contacts

Elizabeth Bouchard, PhD

716-845-1300Elizabeth.Bouchard@roswellpark.rog

Locations

Roswell Park Comprehensive Cancer Center

Recruiting

Buffalo, New York, United States, 14263

Contacts

Elizabeth Bouchard, MD

716-845-8357elizabeth.Bouchard@roswellpark.org

More Information

Sponsor

Roswell Park Cancer Institute

Last update posted

Apr 23, 2026

Last verified

Apr, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Roswell Park Cancer Institute on 2026-04-23.